Clinical Trial Update: Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled Study [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a one-year, double-blind, controlled Phase 2/3 study evaluating maintenance rTMS for treatment-resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Centre hospitalier de Ville-Evrard, France | Conditions: Major Depressive Disorder | Phase 2, Phase 3 | Status: UNKNOWN